Skip to main content
Top
Published in: BMC Health Services Research 1/2019

Open Access 01-12-2019 | Research article

Pharmaceutical marketing strategies’ influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples

Author: Micheline Khazzaka

Published in: BMC Health Services Research | Issue 1/2019

Login to get access

Abstract

Background

Drug companies rely on their marketing activities to influence physicians. Previous studies showed that pharmaceutical companies succeeded to manage physicians prescribing behavior in developed countries. However, very little studies investigated the impact of pharmaceutical marketing strategies on prescribing pattern in developing countries, middle-eastern countries. The objective of this research was to examine the influence of drug companies’ strategies on physicians’ prescription behavior in the Lebanese market concerning physicians’ demographic variables quantitatively. Moreover, this study tested whether Lebanese physicians considered gifts and samples acceptance as an ethical practice.

Methods

Sampling was done by using a non-probability method. An online cross-sectional study was conducted through WhatsApp. A self-administered questionnaire survey was conducted during the months of February and March 2018. Cronbach’s Alpha reliability coefficient was calculated. Data were statistically analyzed by using IBM SPSS statistics version 24 software. Chi-square and Cramer’s v tests were used to finding sign correlation, and Spearman test was used to measure the strength and direction of a relationship between variables.

Results

Results found that pharmaceutical marketing strategies are correlated to physicians’ prescribing behavior. We demonstrated that the majority of the promotional tools tested were mostly or sometimes motivating physicians to prescribe promoted drugs. The major tools that physicians agreed to be mostly motivated by are visits of medical representatives and drug samples while sales calls made by pharmaceutical companies are the less influential tool. Regarding gift acceptance, this study demonstrated that physicians consider gifts’ acceptance as a non-ethical practice. Results showed that most physicians use free samples to treat their patients.
We demonstrated that there is a relationship between physicians’ prescribing pattern and their age, gender and the location of practice.

Conclusions

Findings of this study provided an insightful work, serving as one of the first humble steps in the imminent direction of merging this paper with the previous literature. From a managerial perspective, pharmaceutical marketing managers of drug companies can use the research findings to design better their strategies directed to the Lebanese physicians who can also benefit from the results obtained.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chiu, H. (2005). Selling drugs: marketing strategies in the pharmaceutical industry and their effect on healthcare and research. Explorations. Chiu, H. (2005). Selling drugs: marketing strategies in the pharmaceutical industry and their effect on healthcare and research. Explorations.
2.
go back to reference Marco CA, Moskop JC, Solomon RC, Geiderman JM, Larkin GL. Gifts to physicians from the pharmaceutical industry: an ethical analysis. Ann Emerg Med. 2006;48(5):513–21.PubMedCrossRef Marco CA, Moskop JC, Solomon RC, Geiderman JM, Larkin GL. Gifts to physicians from the pharmaceutical industry: an ethical analysis. Ann Emerg Med. 2006;48(5):513–21.PubMedCrossRef
3.
go back to reference Goyal R, Pareek P. A review article on prescription behavior of doctors, influenced by the medical representative in Rajasthan, India. IOSR J Bus Manag. 2013;8(1):56–60.CrossRef Goyal R, Pareek P. A review article on prescription behavior of doctors, influenced by the medical representative in Rajasthan, India. IOSR J Bus Manag. 2013;8(1):56–60.CrossRef
4.
go back to reference De Laat E, Windmeijer F, Douven RCMH. How does pharmaceutical marketing influence doctors’ prescribing behaviour? Den Haag: CPB; 2002. De Laat E, Windmeijer F, Douven RCMH. How does pharmaceutical marketing influence doctors’ prescribing behaviour? Den Haag: CPB; 2002.
5.
go back to reference Seaman M. New pharma ethics rules eliminate gifts and meals. USA Today. 2008. Seaman M. New pharma ethics rules eliminate gifts and meals. USA Today. 2008.
6.
go back to reference Gönül FF, Carter F, Petrova E, Srinivasan K. Promotion of prescription drugs and its impact on physicians’ choice behavior. J Mark. 2001;65(3):79–90.CrossRef Gönül FF, Carter F, Petrova E, Srinivasan K. Promotion of prescription drugs and its impact on physicians’ choice behavior. J Mark. 2001;65(3):79–90.CrossRef
7.
go back to reference Al-Areefi MA, Hassali MA. Physicians’ perceptions of medical representative visits in Yemen: a qualitative study. BMC Health Serv Res. 2013;13(1):331.PubMedPubMedCentralCrossRef Al-Areefi MA, Hassali MA. Physicians’ perceptions of medical representative visits in Yemen: a qualitative study. BMC Health Serv Res. 2013;13(1):331.PubMedPubMedCentralCrossRef
8.
go back to reference Tahmasebi N, Kebriaeezadeh A. Evaluation of factors affecting prescribing behaviors, in Iran pharmaceutical market by econometric methods. Iran J Pharm Res. 2015;14(2):651.PubMedPubMedCentral Tahmasebi N, Kebriaeezadeh A. Evaluation of factors affecting prescribing behaviors, in Iran pharmaceutical market by econometric methods. Iran J Pharm Res. 2015;14(2):651.PubMedPubMedCentral
9.
go back to reference Buckley J. Pharmaceutical marketing-time for change. Electron J Bus Ethics Org Stud. 2004;9(2). Buckley J. Pharmaceutical marketing-time for change. Electron J Bus Ethics Org Stud. 2004;9(2).
11.
go back to reference Lamont J, Favor C. Distributive justice. In: Handbook of political theory; 2004. p. 1. Lamont J, Favor C. Distributive justice. In: Handbook of political theory; 2004. p. 1.
12.
go back to reference Sen A, Siebert H. Markets and the Freedom to Choose. In: The ethical foundations of the market economy. Tubingen: J.C.B. Mohr; 1994. Sen A, Siebert H. Markets and the Freedom to Choose. In: The ethical foundations of the market economy. Tubingen: J.C.B. Mohr; 1994.
13.
go back to reference Mack P. Utilitarian ethics in healthcare. Int J Comput Integr Manuf. 2004;12(3):63–72. Mack P. Utilitarian ethics in healthcare. Int J Comput Integr Manuf. 2004;12(3):63–72.
14.
go back to reference Lantos GP. In Defense of advertising: arguments from reason, ethical egoism, and laissez-faire capitalism; 1995. Lantos GP. In Defense of advertising: arguments from reason, ethical egoism, and laissez-faire capitalism; 1995.
15.
go back to reference Kirkpatrick J. Ethical Theory in Marketing. In: Marketing Education: Challenges, Opportunities and Solutions: Proceedings of the Western Marketing Educators’ Association Conference; 1989. p. 50–3. Kirkpatrick J. Ethical Theory in Marketing. In: Marketing Education: Challenges, Opportunities and Solutions: Proceedings of the Western Marketing Educators’ Association Conference; 1989. p. 50–3.
16.
go back to reference Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic?: a survey of physicians. Arch Intern Med. 2003;163(18):2213–8.PubMedCrossRef Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic?: a survey of physicians. Arch Intern Med. 2003;163(18):2213–8.PubMedCrossRef
17.
go back to reference Kitchener KS. Intuition, critical evaluation and ethical principles: the foundation for ethical decisions in counseling psychology. Couns Psychol. 1984;12(3):43–55.CrossRef Kitchener KS. Intuition, critical evaluation and ethical principles: the foundation for ethical decisions in counseling psychology. Couns Psychol. 1984;12(3):43–55.CrossRef
18.
go back to reference Denman RB, Purow B, Rubenstein R, Miller DL. Hammerhead ribozyme cleavage of hamster prion pre-mRNA in complex cell-free model systems. Biochem Biophys Res Commun. 1992;186(2):1171–7.PubMedCrossRef Denman RB, Purow B, Rubenstein R, Miller DL. Hammerhead ribozyme cleavage of hamster prion pre-mRNA in complex cell-free model systems. Biochem Biophys Res Commun. 1992;186(2):1171–7.PubMedCrossRef
19.
go back to reference The Lebanese Ministry of Public Health (MOPH), 2016, The Lebanese Code of Ethics: a New Milestone. The Lebanese Ministry of Public Health (MOPH), 2016, The Lebanese Code of Ethics: a New Milestone.
20.
go back to reference Van den Bulte C, Lilien GL. Medical innovation revisited: social contagion versus marketing effort. Am J Sociol. 2001;106(5):1409–35.CrossRef Van den Bulte C, Lilien GL. Medical innovation revisited: social contagion versus marketing effort. Am J Sociol. 2001;106(5):1409–35.CrossRef
21.
go back to reference Berndt ER, Pindyck RS, Azoulay P. Consumption externalities and diffusion in pharmaceutical markets: antiulcer drugs. J Ind Econ. 2003;51(2):243–70.CrossRef Berndt ER, Pindyck RS, Azoulay P. Consumption externalities and diffusion in pharmaceutical markets: antiulcer drugs. J Ind Econ. 2003;51(2):243–70.CrossRef
22.
go back to reference Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J. Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care. 2003;41(8):895–908.PubMedCrossRef Tamblyn R, McLeod P, Hanley JA, Girard N, Hurley J. Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care. 2003;41(8):895–908.PubMedCrossRef
23.
go back to reference Gilly MC, Zeithaml VA. The elderly consumer and adoption of technologies. J Consum Res. 1985;12(3):353–7.CrossRef Gilly MC, Zeithaml VA. The elderly consumer and adoption of technologies. J Consum Res. 1985;12(3):353–7.CrossRef
24.
go back to reference Mitchell VW, Walsh G. Gender differences in German consumer decision-making styles. J Consum Behav. 2004;3(4):331–46.CrossRef Mitchell VW, Walsh G. Gender differences in German consumer decision-making styles. J Consum Behav. 2004;3(4):331–46.CrossRef
25.
go back to reference Chang J, Samuel N. Internet shopper demographics and buying behaviour in Australia. J Am Acad Bus. 2004;5(1/2):171–6. Chang J, Samuel N. Internet shopper demographics and buying behaviour in Australia. J Am Acad Bus. 2004;5(1/2):171–6.
26.
go back to reference Fischer E, Arnold SJ. Sex, gender identity, gender role attitudes, and consumer behavior. Psychol Mark. 1994;11(2):163–82.CrossRef Fischer E, Arnold SJ. Sex, gender identity, gender role attitudes, and consumer behavior. Psychol Mark. 1994;11(2):163–82.CrossRef
27.
go back to reference Inman W, Pearce G. Prescriber profile and post-marketing surveillance. Lancet. 1993;342(8872):658–61.PubMedCrossRef Inman W, Pearce G. Prescriber profile and post-marketing surveillance. Lancet. 1993;342(8872):658–61.PubMedCrossRef
28.
go back to reference Rogers EM. Diffusion of innovations: Simon and Schuster; 2010. Rogers EM. Diffusion of innovations: Simon and Schuster; 2010.
29.
go back to reference Narayanan S, Manchanda P, Chintagunta PK. Temporal differences in the role of marketing communication in new product categories. J Mark Res. 2005;42(3):278–90.CrossRef Narayanan S, Manchanda P, Chintagunta PK. Temporal differences in the role of marketing communication in new product categories. J Mark Res. 2005;42(3):278–90.CrossRef
30.
go back to reference Hahn M, Park S, Krishnamurthi L, Zoltners AA. Analysis of new product diffusion using a four-segment trial-repeat model. Mark Sci. 1994;13(3):224–47.CrossRef Hahn M, Park S, Krishnamurthi L, Zoltners AA. Analysis of new product diffusion using a four-segment trial-repeat model. Mark Sci. 1994;13(3):224–47.CrossRef
31.
go back to reference Vakratsas D, Ambler T. How advertising works: what do we really know? J Mark. 1999;63(1):26–43.CrossRef Vakratsas D, Ambler T. How advertising works: what do we really know? J Mark. 1999;63(1):26–43.CrossRef
32.
go back to reference Dorfman R, Steiner PO. Optimal advertising and optimal quality. Am Econ Rev. 1954:826–36. Dorfman R, Steiner PO. Optimal advertising and optimal quality. Am Econ Rev. 1954:826–36.
33.
go back to reference Turley LW, LeBlanc RP. Evoked sets: a dynamic process model. J Mark Theory Pract. 1995;3(2):28–36.CrossRef Turley LW, LeBlanc RP. Evoked sets: a dynamic process model. J Mark Theory Pract. 1995;3(2):28–36.CrossRef
34.
go back to reference Mott DA, Schommer JC, Doucette WR, Kreling DH. Agency theory, drug formularies, and drug product selection: implications for public policy. J Public Policy Mark. 1998:287–95. Mott DA, Schommer JC, Doucette WR, Kreling DH. Agency theory, drug formularies, and drug product selection: implications for public policy. J Public Policy Mark. 1998:287–95.
35.
go back to reference Netemeyer R, Ryn MV, Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.CrossRef Netemeyer R, Ryn MV, Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.CrossRef
36.
go back to reference Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225–30.PubMedCrossRef Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362(9391):1225–30.PubMedCrossRef
37.
go back to reference Eisenhardt KM. Agency theory: an assessment and review. Acad Manag Rev. 1989;14(1):57–74.CrossRef Eisenhardt KM. Agency theory: an assessment and review. Acad Manag Rev. 1989;14(1):57–74.CrossRef
38.
go back to reference Broderick A. Role theory and the management of service encounters. Serv Ind J. 1999;19(2):117–31.CrossRef Broderick A. Role theory and the management of service encounters. Serv Ind J. 1999;19(2):117–31.CrossRef
39.
go back to reference Barnes ML. Marketing to a segment of one. Pharm Exec. 2003;23(3):110. Barnes ML. Marketing to a segment of one. Pharm Exec. 2003;23(3):110.
40.
go back to reference Sheth JN, Parvatiyar A. Relationship marketing in consumer markets: antecedents and consequences. J Acad Mark Sci. 1995;23(4):255–71.CrossRef Sheth JN, Parvatiyar A. Relationship marketing in consumer markets: antecedents and consequences. J Acad Mark Sci. 1995;23(4):255–71.CrossRef
41.
go back to reference Hajjar R, Bassatne A, Cheaito MA, Naser El Dine R, Traboulsy S, Haddadin F, Honein-AbouHaidar G, Akl EA. Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: a qualitative study. PLoS ONE. 2017;12(9). Hajjar R, Bassatne A, Cheaito MA, Naser El Dine R, Traboulsy S, Haddadin F, Honein-AbouHaidar G, Akl EA. Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: a qualitative study. PLoS ONE. 2017;12(9).
42.
go back to reference Avorn J, Chren M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73(1):4–8.PubMedCrossRef Avorn J, Chren M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73(1):4–8.PubMedCrossRef
43.
go back to reference Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995;273(16):1296–8.PubMedCrossRef Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995;273(16):1296–8.PubMedCrossRef
44.
go back to reference McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, et al. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Intern Med J. 2006;36(9):571–8.PubMedCrossRef McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, et al. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Intern Med J. 2006;36(9):571–8.PubMedCrossRef
45.
go back to reference Alosaimi F, Alkaabba A, Qadi M, Albahlal A, Alabdulkarim Y, Alabduljabbar M, et al. Acceptance of pharmaceutical gifts. Variability by specialty and job rank in a Saudi healthcare setting. Saudi Med J. 2013;34(8):854–60.PubMed Alosaimi F, Alkaabba A, Qadi M, Albahlal A, Alabdulkarim Y, Alabduljabbar M, et al. Acceptance of pharmaceutical gifts. Variability by specialty and job rank in a Saudi healthcare setting. Saudi Med J. 2013;34(8):854–60.PubMed
46.
go back to reference Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295(4):429–33.PubMedCrossRef Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295(4):429–33.PubMedCrossRef
47.
go back to reference Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373–80.PubMedCrossRef Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373–80.PubMedCrossRef
48.
go back to reference Steunman M, Shilpak M, McPhee S. Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med. 2001;110(7):551–7.CrossRef Steunman M, Shilpak M, McPhee S. Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med. 2001;110(7):551–7.CrossRef
49.
go back to reference Cutts C, Tett SE. Influences on doctors’ prescribing: is geographical remoteness a factor? Aust J Rural Health. 2003;11(3):124–30.PubMed Cutts C, Tett SE. Influences on doctors’ prescribing: is geographical remoteness a factor? Aust J Rural Health. 2003;11(3):124–30.PubMed
50.
51.
go back to reference Alssageer MA, Kowalski SR. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives? Pan Afr Med J. 2013;14:132.PubMedPubMedCentralCrossRef Alssageer MA, Kowalski SR. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives? Pan Afr Med J. 2013;14:132.PubMedPubMedCentralCrossRef
52.
go back to reference Ghaith A, Aldmour H, Alabbadi H. Investigating the effect of pharmaceutical companies’ gifts on doctors’ prescribing behavior in Jordan. Eur J Soc Sci. 2012;36(4):528–36. Ghaith A, Aldmour H, Alabbadi H. Investigating the effect of pharmaceutical companies’ gifts on doctors’ prescribing behavior in Jordan. Eur J Soc Sci. 2012;36(4):528–36.
53.
go back to reference Mikhael EM, Alhilali DN. Gift acceptance and its effect on prescribing behavior among Iraqi specialist physicians. Pharmacol Pharm. 2014;5(7):705–15.CrossRef Mikhael EM, Alhilali DN. Gift acceptance and its effect on prescribing behavior among Iraqi specialist physicians. Pharmacol Pharm. 2014;5(7):705–15.CrossRef
Metadata
Title
Pharmaceutical marketing strategies’ influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples
Author
Micheline Khazzaka
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2019
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-019-3887-6

Other articles of this Issue 1/2019

BMC Health Services Research 1/2019 Go to the issue